PHASE II STUDY OF THE ROLE OF ANTI-CEA ANTIBODY IMMUNOSCINTIGRAPHY & POSITRON EMISSION TOMOGRAPHY IN THE LOCALIZATION OF RECURRENT COLORECTAL CARCINOMA IN PATIENTS WITH RISING SERUM CEA LEVELS IN THE ABSENCE OF IMAGEABLE DISEASE BY CONVENTIONAL MODALITIES: